Clinical Trial Update: A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 safety confirmation study of lenalidomide with dexamethasone in Japanese patients with previously treated multiple myeloma completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• lenalidomide with dexamethasone

Snippet

Sponsor: Celgene | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2016-06-14